SBFMW
Sunshine Biopharma Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$0.03
+2.00%Price chart
Aug 17Aug 25Sep 2Sep 18Oct 2Oct 8Oct 15Oct 30
Key dataOct 30, 2026
Open$0.03
From 52W high−92.65%
Volume5001.00
Market cap$118617.94
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataOct 30, 2026
Open
$0.03
From 52W high
−92.65%
Volume
5001.00
Market cap
$118617.94
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
2.5x
P/E (TTM)
—
RSI (14)
45.7
MomentumView details →
1D Return
+2.00%
YTD Return
−86.58%
SummaryUpdated Jun 1, 2026
Sunshine Biopharma, Inc. (NASDAQ:SBFM) is a Canadian pharmaceutical and nutritional supplement company founded and headquartered in Pointe-Claire, Canada. The company went public on February 15, 2022, representing a relatively recent entrant to the public markets. Sunshine Biopharma operates as a dual-focus enterprise, combining early-stage anticancer drug development with an established nutritional supplement business that generates the majority of its current revenue.
Similar companies
Latest newsMore news →
Sunshine Biopharma announced a one-for-twenty reverse stock split of its common stock, effective at market open on October 26, 2026, to regain compliance with NASDAQ, INC.'s minimum bid price requirement.9d agoSunshine Biopharma Inc. announced the pricing of a public offering expected to generate approximately $6.0 million in gross proceeds, comprising 10,909,083 common or pre-funded units with two Series D warrants per unit.23d ago